227 related articles for article (PubMed ID: 33403869)
1. Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program.
Dong OM; Bates J; Chanfreau-Coffinier C; Naglich M; Kelley MJ; Meyer LJ; Icardi M; Vassy JL; Sriram P; Heise CW; Rivas S; Ribeiro M; Jacobitz R; Rozelle S; Chapman JG; Voora D
Pharmacogenomics; 2021 Feb; 22(3):137-144. PubMed ID: 33403869
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites.
Dong OM; Roberts MC; Wu RR; Voils CI; Sperber N; Gavin KL; Bates J; Chanfreau-Coffinier C; Naglich M; Kelley MJ; Vassy JL; Sriram P; Heise CW; Rivas S; Ribeiro M; Chapman JG; Voora D
Pharmacogenomics; 2021 Nov; 22(17):1121-1133. PubMed ID: 34704830
[No Abstract] [Full Text] [Related]
3. The Ubiquitous Pharmacogenomics consortium: making effective treatment optimization accessible to every European citizen.
Manson LE; van der Wouden CH; Swen JJ; Guchelaar HJ
Pharmacogenomics; 2017 Jul; 18(11):1041-1045. PubMed ID: 28685652
[No Abstract] [Full Text] [Related]
4. Prescription medications with actionable pharmacogenomic recommendations in Veterans Health Administration patients.
Maghari S; Gallo T; Rivas S; German A; Nguyen Le MQ; Abbaszadegan H; Zubriski MA; Heise CW; Landas ND
Pharmacogenomics; 2023 Jun; 24(9):501-508. PubMed ID: 37435738
[No Abstract] [Full Text] [Related]
5. Patient Perspectives of Barriers and Facilitators for the Uptake of Pharmacogenomic Testing in Veterans Affairs' Pharmacogenomic Testing for the Veterans (PHASER) Program.
Melendez K; Gutierrez-Meza D; Gavin KL; Alagoz E; Sperber N; Wu RR; Silva A; Pati B; Voora D; Hung A; Roberts MC; Voils CI
J Pers Med; 2023 Sep; 13(9):. PubMed ID: 37763135
[TBL] [Abstract][Full Text] [Related]
6. Characterizing Pharmacogenomic-Guided Medication Use With a Clinical Data Repository.
Mathias PC; Hendrix N; Wang WJ; Keyloun K; Khelifi M; Tarczy-Hornoch P; Devine B
Clin Pharmacol Ther; 2017 Aug; 102(2):340-348. PubMed ID: 28073152
[TBL] [Abstract][Full Text] [Related]
7. Veterans Health Administration: Implementation of pharmacogenomic clinical decision support with statin medications and the SLCO1B1 gene as an exemplar.
Tomcsanyi KM; Tran KA; Bates J; Cunningham FE; Silverman R; Norris AK; Moore VR; Voora D
Am J Health Syst Pharm; 2023 Aug; 80(16):1082-1089. PubMed ID: 37210707
[TBL] [Abstract][Full Text] [Related]
8. Non-interventional cardiologists' perspectives on the role of pharmacogenomic testing in cardiovascular medicine.
Deininger KM; Page RL; Lee YM; Kauffman YS; Johnson SG; Oreschak K; Aquilante CL
Per Med; 2019 Mar; 16(2):123-132. PubMed ID: 30543145
[TBL] [Abstract][Full Text] [Related]
9. Implementing Pharmacogenomics in Europe: Design and Implementation Strategy of the Ubiquitous Pharmacogenomics Consortium.
van der Wouden CH; Cambon-Thomsen A; Cecchin E; Cheung KC; Dávila-Fajardo CL; Deneer VH; Dolžan V; Ingelman-Sundberg M; Jönsson S; Karlsson MO; Kriek M; Mitropoulou C; Patrinos GP; Pirmohamed M; Samwald M; Schaeffeler E; Schwab M; Steinberger D; Stingl J; Sunder-Plassmann G; Toffoli G; Turner RM; van Rhenen MH; Swen JJ; Guchelaar HJ;
Clin Pharmacol Ther; 2017 Mar; 101(3):341-358. PubMed ID: 28027596
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of major pharmacogenomics pretest counseling themes: a multisite comparison.
Wake DT; Bell GC; Gregornik DB; Ho TT; Dunnenberger HM
Pharmacogenomics; 2021 Feb; 22(3):165-176. PubMed ID: 33461326
[TBL] [Abstract][Full Text] [Related]
11. Primary care physician experiences with integrated pharmacogenomic testing in a community health system.
Lemke AA; Hutten Selkirk CG; Glaser NS; Sereika AW; Wake DT; Hulick PJ; Dunnenberger HM
Per Med; 2017 Sep; 14(5):389-400. PubMed ID: 29754567
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Implementation of Pharmacogenomic Testing in a Pediatric Tertiary Care Setting.
Cohn I; Manshaei R; Liston E; Okello JBA; Khan R; Curtis MR; Krupski AJ; Jobling RK; Kalbfleisch K; Paton TA; Reuter MS; Hayeems RZ; Verstegen RHJ; Goldman A; Kim RH; Ito S
JAMA Netw Open; 2021 May; 4(5):e2110446. PubMed ID: 34037732
[TBL] [Abstract][Full Text] [Related]
13. Development of the PGx-Passport: A Panel of Actionable Germline Genetic Variants for Pre-Emptive Pharmacogenetic Testing.
van der Wouden CH; van Rhenen MH; Jama WOM; Ingelman-Sundberg M; Lauschke VM; Konta L; Schwab M; Swen JJ; Guchelaar HJ
Clin Pharmacol Ther; 2019 Oct; 106(4):866-873. PubMed ID: 31038729
[TBL] [Abstract][Full Text] [Related]
14. Integration of a clinical pharmacist practitioner-led pharmacogenomics service in a Veterans Affairs hematology/oncology clinic.
Dreischmeier E; Hecht H; Crocker E; Seckel E; Wilcox A; Fletcher C; Piccolo J
Am J Health Syst Pharm; 2024 May; ():. PubMed ID: 38733328
[TBL] [Abstract][Full Text] [Related]
15. Implementation of Pharmacogenetic Testing Within the Veterans Health Administration From 2011 to 2013.
Lynch J; DuVall SL; Berse B; Whatley A; St Pierre C; Oloruntoba O; Hunt CM
Mil Med; 2016 Oct; 181(10):1375-1381. PubMed ID: 27753578
[TBL] [Abstract][Full Text] [Related]
16. Considerations for pharmacogenomic testing in a health system.
Gammal RS; Caudle KE; Klein TE; Relling MV
Genet Med; 2019 Aug; 21(8):1886-1887. PubMed ID: 30631112
[No Abstract] [Full Text] [Related]
17. A prospective study to determine the clinical utility of pharmacogenetic testing of veterans with treatment-resistant depression.
McCarthy MJ; Chen Y; Demodena A; Leckband SG; Fischer E; Golshan S; Suppes T; Kelsoe JR
J Psychopharmacol; 2021 Aug; 35(8):992-1002. PubMed ID: 33938307
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitous Pharmacogenomics (U-PGx): The Time for Implementation is Now. An Horizon2020 Program to Drive Pharmacogenomics into Clinical Practice.
Cecchin E; Roncato R; Guchelaar HJ; Toffoli G;
Curr Pharm Biotechnol; 2017; 18(3):204-209. PubMed ID: 28044932
[TBL] [Abstract][Full Text] [Related]
19. Study design and implementation of the PRecision Medicine In MEntal health Care (PRIME Care) Trial.
Oslin DW; Chapman S; Duvall SL; Gelernter J; Ingram EP; Kranzler HR; Lehmann LS; Lynch JA; Lynch KG; Pyne JM; Shih MC; Stone A; Thase ME; Wray LO
Contemp Clin Trials; 2021 Feb; 101():106247. PubMed ID: 33316457
[TBL] [Abstract][Full Text] [Related]
20. Multisite investigation of strategies for the clinical implementation of pre-emptive pharmacogenetic testing.
Duarte JD; Dalton R; Elchynski AL; Smith DM; Cicali EJ; Lee JC; Duong BQ; Petry NJ; Aquilante CL; Beitelshees AL; Empey PE; Johnson JA; Obeng AO; Pasternak AL; Pratt VM; Ramsey LB; Tuteja S; Van Driest SL; Wiisanen K; Hicks JK; Cavallari LH;
Genet Med; 2021 Dec; 23(12):2335-2341. PubMed ID: 34282303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
